AstraZeneca Innovation Challenge in Lung Cancer

Presented by AstraZeneca & Plug and Play

AstraZeneca Innovation Challenge in Lung Cancer

Empowering Primary Care Providers and Pulmonologists to Advance Diagnosis and Precision Care in Lung Cancer

Despite advances in lung cancer treatment, significant delays persist in the diagnostic pathway, particularly between symptom onset and appropriate imaging or testing.

Furthermore, once diagnosed, many patients still do not receive guideline-recommended biomarker testing due to system-level gaps, limited awareness, and workflow inefficiencies. Primary care and pulmonology practices, especially outside major academic centers, are often under-equipped to manage this complexity.

The Opportunity

Challenge Timeline

Sept. 17

Application Opened

Oct. 12

Application Closed

Oct. 22

Finalists Announced

Nov. 6

Startup Selection & Pitch Day

Late Nov.

Winners announced

 

What we're looking for:

Early Detection and Intervention: Implement new tools that can help clinicians recognize and act on early, subtle symptoms and nodules leading to quicker, more effective diagnoses.

Integrated Care Pathways: Solutions that create seamless, integrated workflows that connect primary care physicians and specialists. These tools can guide them through the entire process, from first symptoms to referral, imaging, and molecular testing.

Increase Biomarker Testing Rates: Integrate biomarker testing as a critical part of diagnosis, especially in community healthcare settings, to ensure broader patient access to personalized treatments.

Enhance Clinical Decision Support: Integrate real-time clinical decision tools directly into existing EMRs. This could involve creating prompts and flags for at-risk patients and embedding the latest guidelines to help clinicians at the point of care.

Bridging Educational Gaps: Tools that support clinicians to be fully aware of updated guidelines for early detection, screening eligibility, or biomarker-directed therapy.

 


 

Eligibility

  • Regulatory: FDA-cleared, CE-marked, or equivalent or in advanced stages of submission are preferred. Commercial-stage product or clinical deployment underway

  • HIPAA/GDPR compliant

  • Willingness to co-develop or scale with biopharma

Challenge Details

Region of Focus

North America

Other geographies will be considered if the product is commercialized and has clear and imminent expansion plans into the U.S.

 

Target Areas

Digital health, diagnostics, or AI-enabled solutions applicable to primary care, pulmonology, or oncology. 

Technologies used in other diseases areas are in scope, if adaptable to lung cancer or precision oncology.

Potential for Integration

Integration into lung cancer workflows (e.g. triage, referral, biomarker testing). 

Solutions that enhance EMR integration, clinical decision support, early detection, biomarker workflow orchestration, or telehealth triage.                  

Apply Now

FAQs

Who can apply?

U.S.-based or U.S.-ready startups with a solution that fits the challenge focus.

How can I apply?

Submit your application through the online form before the deadline.

Can I apply with multiple solutions?

Yes, as long as each solution meets the eligibility criteria.

When is the deadline for the application?

October 10th, 2025. Late applications may be considered if an extension is announced.

What’s in this for me/my business?

A chance to explore pilot opportunities with AstraZeneca, and exposure to their organization, as well as to Plug and Play’s global network.

Are applicants guaranteed investment?

No. This challenge focuses on pilots and partnerships, not direct investment.

What kind of solutions are you looking for?

Digital solutions that empower primary care providers and pulmonologists to advance diagnosis and precision medicine, covering early detection, care coordination, patient access, CDS, or education approaches.

How can I ask a question?

Email the Plug and Play Health team at l.soto@pnptc.com for any inquiries about the challenge or application process.

Plug and Play Around the World

Discover our global locations

We have a community of experts all over the world. We work as a bridge between Silicon Valley and the rest of the world, making innovation open to anyone, anywhere.

Sign up to our global newsletter